Similar effects of clozapine and olanzapine on ethanol-induced ascorbic acid release in the prefrontal cortex of freely moving mice

Pharmazie

Volumn 62, Issue 2, 2007, Pages 158-160

  Hou, Yue ^a   Wu, Chun Fu ^a   Jing, Yu Yang ^a   Pei, Fei Gu ^a   Xiu, Li Bi ^a   Fang, Dai ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ASCORBIC ACID; CLOZAPINE; OLANZAPINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG RELEASE; MALE; MOTION ANALYSIS SYSTEM; MOUSE; NEUROCHEMISTRY; NONHUMAN; PREFRONTAL CORTEX;

ANIMALS; ANTIPSYCHOTIC AGENTS; ASCORBIC ACID; BENZODIAZEPINES; CENTRAL NERVOUS SYSTEM DEPRESSANTS; CLOZAPINE; ETHANOL; MALE; MICE; MICRODIALYSIS; PREFRONTAL CORTEX;

EID: 33847141521     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2007.2.6692     Document Type: Article

References (13)

1. Bhana N, Foster RH, Olney R, Plosker GL (2001) Olanzapine: An updated review of its use in the management of schizophrenia. Drugs 61: 111-161.
2. Dazzi L, Seu E, Cherchi G, Biggio G (2004) Inhibition of stress-induced dopamine output in the rat prefrontal cortex by chronic treatment with olanzapine. Biol Psychiatry 55: 477-483.
3. Dorris RL (1987) Ascorbic acid reduces accumulation of [3H]-spiperone in mouse striatum in vivo. Proc Soc Exp Biol Med 186: 13-16.
4. Grunewald RA (1993) Ascorbic acid in the brain. Brain Res Rev 18: 123-133.
5. Hadjiconstantinou M, Neff NH (1983) Ascorbic acid could be hazardous to your experiments: a commentary on dopamine receptor binding sites with speculation on a role for ascorbic acid in neuronal function. Neuropharmacology 22: 939-943.
6. Heikkila RE, Cabbat FS, Manzino L (1982) Inhibitory effects of ascorbic acid on the binding of [3H]dopamine antagonists to neostriatal membrane preparations: relationship to lipid peroxidation. J Neurochem 38: 1000-1006.
7. Hou Y, Wu CF, Yang JY, He X, Guo T (2006) Ethanol similarly induces ascorbic acid release in the prefrontal cortex and striatum of freely moving mice. Yakugaku Zasshi 126: 671-675.
8. Hou Y, Yang JY, Wu CF, Huang M (2005) Effects of clozapine, olanzapine and haloperidol on ethanol-induced ascorbic acid release in mouse striatum. Prog Neuropsychopharmacol Biol Psychiatry 29: 83-89.
9. Kayaalp SO, Rubenstein JS, Neff NH (1981) Inhibition of dopamine D1 and D2 binding sites in neuronal tissue by ascorbate. Neuropharmacology 30: 409-410.
10. Mefford IN, Oke AF, Adams RN (1981) Regional distribution of ascorbate in human brain. Brain Res 212: 223-226.
11. Ninan I, Jardemark KE, Wang RY (2003) Olanzapine and clozapine but not haloperidol reverse subchronic phencyclidine-induced functional hyperactivity of N-methyl-D-aspartate receptors in pyramidal cells of the rat medial prefrontal cortex. Neuropharmacology 44: 462-472.
12. Rebec GV, Pierce RC (1994) A vitamin as neuromodulator: ascorbic acid release into the extracellular fluid of the brain regulates dopaminergic and glutamatergic transmission. Prog Neurobiol 43: 537-565.
13. Schenk JO, Miller E, Gaddis R, Adams RN (1982) Homeostatic control of ascorbate concentration in the CNS extracellular fluid. Brain Res 253: 353-356.